plus 4, Have You Heard Of Us!! Sign Up And Learn About Us!! SNWT,VVUS,GRMN ... - TMCnet |
- Have You Heard Of Us!! Sign Up And Learn About Us!! SNWT,VVUS,GRMN ... - TMCnet
- Auto Expo reflects India's growing global might - Hindu Business Line
- Car dealers hope federal tax break deadline boost sales this week - San Jose Mercury News
- Tax break nearly over for new-car buyers - Toledo Blade
- Former NFL player, Reno car salesman Rick Kane dies at 55 - Reno Gazette
Have You Heard Of Us!! Sign Up And Learn About Us!! SNWT,VVUS,GRMN ... - TMCnet Posted: 29 Dec 2009 08:35 AM PST
(M2 PressWIRE Via Acquire Media NewsEdge) STOCK MARKETING INC PRESENTS : (PINKSHEETS: ZVTK) Zevotek, Inc., (NASDAQ: VVUS) VIVUS, Inc., (NASDAQ: GRMN) Garmin Ltd., (NASDAQ: TKTM) Ticketmaster Entertainment, Inc., (NASDAQ: APPY) AspenBio Pharma, Inc., (PINKSHEETS: ZVTK) Zevotek, Inc. www.StockMarketingInc.com To sign up for our free Profiles & Alerts :: visit http://www.StockMarketingInc.com email us!! info@StockMarketingInc.com or call 1-866-583-8960 ------------------------------------------------------------------------------------------------------------------------------------------------------------ (OTCBB: SNWT - San West, Inc.) LATEST NEWS!! San West Inc. Releases Significant Milestones for 2009 and 2010 Outlook Management Reflects on a Transformational 2009, Outlines Aggressive Growth Initiatives for 2010 SAN DIEGO, CA, Dec 29, 2009 -- San West Inc. (OTCBB: SNWT), an emerging leader in the design, manufacture, sales and repair of off-road recreational vehicles, today provided a business update and reiterated its expectation that 2010 will be another transformational year as the company pushes forward with plans to become a leading global off-road sports producer and retailer. 2009 Business Review Operational Developments -- Entered the public marketplace via reverse merger with Human Bio-Systems, Inc. in early June and began trading on the OTC Bulletin Board under the symbol HBSY, and changed corporate name and ticker change to San West Inc. and SNWT in late September. -- Launched a new and improved Buggy World website equipped with an e- commerce store to further expand our market reach and broaden our offering and purchasing options for customers. -- Became the exclusive TrophyKart dealership for San Diego County in an agreement expected to generate between $150,000 to $250,000 in annual sales and drastically boost and improve brand notoriety, particularly among the younger demographic. -- Partnered with CountyImports.com -- the 2nd largest online retailer of off-road vehicles and accessories -- in an agreement expected to add at least $3,200,000 in annual revenues to San West's top line and offset the seasonality of our sales levels. -- Subsequently launched an enhanced version of CountyImports.com and announced that sales generated through the website between 11/17/08 and 12/18/09 were approximately $150,000, higher than the corresponding period of 2008, a record year for CountyImports.com. -- Reported revenues for the third quarter of $217,099, an increase of 53.4% and gross profits or $146,336 , representing a gross profit margin of 26.8%. -- Announced that fourth quarter 2009 will by far be the greatest in corporate history. -- Established a promotional credit program -- "The RPM Card" -- to help offset the negative impact of the consumer credit meltdown by providing financing to customers with less than stellar credit ratings. -- Acquired non-exclusive sales & marketing rights for leading off-road sporting brands including Fox Racing, Joiner, and Thor. Market-Related Developments -- Share price has surged from less than one cent to a 52-week high of $1.71 on 10/12 ($0.35 split adjusted). -- Executed a 5 for 1 forward stock split in November of 2009 with the intent of strengthening shareholder value by facilitating increased trading among retail investors. -- Secured $10,000,000 in equity financing from an institutional investor during December which will enable San West to more aggressively pursue synergistic acquisitions. -- Announced a consulting agreement with Hayden IR, a leading North American investor relations firm with a proven track record of transforming micro- cap firms into NYSE and Nasdaq-traded companies. 2010 Outlook 2010 will be another transformational year for San West Inc. During 2009, San West launched a number of strategic initiatives that helped lay the foundation for a premier international off-road sports firm and positioned the company to generate annual revenues in the $6,000,000 to $8,000,000 next year. We strongly believe that our continued relentless pursuance of opportunities that hold the potential to drive growth -- both organically and via acquisition -- during 2010 will help boost annual revenues above initial expectations. We recently obtained $10,000,000 in equity financing which provides an ideal complement to our extremely successful and assiduous expansion initiatives. This capital injection will allow San West to grow our business in ways that were quite recently unimaginable. Corporate/competitor buyouts, major real estate acquisitions, massive advertising investments, expensive product and service development, and sponsorship of major industry events are all now economically feasible to some extent. We are building a one-stop off-road sports superstore, both online and at our first Buggy World brick & mortar location -- and will continue to pursue business ventures that will help broaden our global consumer reach. A few potential avenues for near-term expansion include but are not limited to fortifying existing online sales infrastructure, establishing additional retail locations in "hot" off-road markets, and expanding into new product markets such as personal watercraft (PWC) and motorcycles. From a stock market perspective, our share price has matured significantly over the past 6 to 12 months. We have aligned our organization with some of the most highly esteemed financial services organizations in the world to help create shareholder value, provide maximum transparency into our operations, to articulate our unique value proposition and relay our growth story to the masses, and establish a line of communication to institutional investors. At this point, we would like to thank our faithful shareholders for their interest in 2009 and reiterate our dedication to making 2010 another lucrative year for them and San West Inc. together. We wish everyone a very happy holiday season and a prosperous new year and also look forward to updating the public on our material developments as they arise. About San West Inc. San West designs, manufactures, sells and repairs off-road buggies, and additionally provides aftermarket performance products and accessories for off-road buggies. Products are sold via three divisions: at retail store locations, via the online store and through its growing dealer network. Buggy repair services are sold and fulfilled at the Santee, California retail location. For further information about San West Inc. visit www.CountyImports.com, www.BuggyWorld.net, www.CountyImportParts.com and www.SanWestInc.com. ------------------------------------------------------------------------------------------------------------------------------------------------------------ (NASDAQ: VVUS - VIVUS, Inc.) LATEST NEWS!! VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity MOUNTAIN VIEW, Calif., Dec 29, 2009 -- VIVUS, Inc. (Nasdaq: VVUS), a biopharmaceutical company developing innovative, next-generation medical therapies to address unmet needs in obesity, diabetes and sexual health, announced today that a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration (FDA) seeking approval of Qnexa, its investigational drug for the treatment of obesity, including weight loss and maintenance of weight loss, in patients who are obese or overweight with co-morbidities such as hypertension, type 2 diabetes, dyslipidemia or central adiposity. The NDA submission follows the successful completion of the phase 3 program for Qnexa, including the recently announced results from the two pivotal, year-long phase 3 studies, EQUIP and CONQUER. In these trials, patients treated with all three doses of Qnexa achieved significant percent and categorical weight loss compared to placebo and met regulatory requirements for weight loss products as defined in the current FDA Guidance for Developing Products for Weight Management. Patients treated with Qnexa also had significant dose-related improvements in a variety of secondary endpoints including reductions in cardiovascular and metabolic risk factors. "This NDA filing is a major milestone for VIVUS and the Qnexa program. The weight loss seen in all of the phase 3 trials supports our belief that, if approved, Qnexa could be an effective treatment for patients who are obese or overweight with co-morbidities," stated Leland F. Wilson, chief executive officer for VIVUS. "The weight loss of up to 14.7% (37 pounds) combined with significant improvements in weight-related medical conditions, such as hypertension, diabetes, and dyslipidemia, demonstrates the importance of treating obesity, which has become a major epidemic in the United States and many developed countries. I wish to thank all of the VIVUS employees, contractors and advisors who contributed to the program and made this on-time filing possible." Previously reported highlights from the two 56-week EQUIP and CONQUER studies comprising more than 3,750 patients include: -- Weight loss of up to 14.7% (37 lbs) achieved by patients treated with Qnexa for 56 weeks in the EQUIP study; -- Statistically significant improvements in cardiovascular, metabolic and inflammatory risk factors among patients treated with Qnexa; -- FDA efficacy benchmarks for weight loss agents were exceeded at all three doses of Qnexa tested in the clinical program; -- Completion rates up to 69% were statistically significantly higher than placebo at all three doses of Qnexa, indicating favorable tolerability; and -- Across both 56-week studies, the most commonly reported side effects were dry mouth, tingling and constipation. About the Phase 3 Program The phase 3 clinical program, evaluating Qnexa in more than 4,500 patients, was designed under a Special Protocol Assessment with the U.S. FDA and consists of three trials: EQUATE (OB-301), EQUIP (OB-302) and CONQUER (OB-303). The EQUATE study was a 28-week randomized, double-blind, placebo-controlled, 7-arm, prospective trial with subjects randomized to receive once-a-day treatment with mid- or full-dose Qnexa, the respective constituents, or placebo. The average baseline BMI of the study population was 36.3 kg/m(2) with an average baseline weight of 223 pounds. The EQUIP and CONQUER studies were 56-week, randomized, double-blind, placebo-controlled, 3-arm, prospective trials with patients randomized to receive once-a-day treatment with low-, mid-, or full-dose Qnexa, or placebo. In EQUIP, the average baseline BMI of the study population was 42.1 kg/m(2) with an average baseline weight of 256 pounds; in CONQUER, the average baseline BMI of the study population was 36.6 kg/m(2) with an average baseline weight of 227 pounds. All patients were asked to follow a hypocaloric diet representing a 500-calorie/day deficit and advised to implement a simple lifestyle modification program. About Qnexa Qnexa (Q-NEX-uh) is an investigational drug being developed to address weight loss. Qnexa is a once-a-day, proprietary, oral, controlled-release formulation of low dose phentermine and topiramate, which is believed to address both appetite and satiety - the two main mechanisms that impact eating behavior - in one capsule. In phase 2 and 3 clinical studies, Qnexa has demonstrated significant weight loss, glycemic control, and improvement in cardiovascular risk factors. About VIVUS VIVUS is a biopharmaceutical company developing innovative, next-generation therapies to address unmet needs in obesity, diabetes and sexual health. The company's lead product in clinical development, Qnexa, has recently completed phase 3 clinical trials for the treatment of obesity and an NDA was submitted to the FDA in December 2009. Qnexa is currently in phase 2 clinical development for the treatment of type 2 diabetes. In the area of sexual health, VIVUS is in phase 3 development with avanafil, a potentially best-in-class PDE5 inhibitor, and in phase 2 development of Luramist(TM) for the treatment of hypoactive sexual desire disorder (HSDD) in women. MUSE(R) (alprostadil), a first generation therapy for the treatment of ED, is already on the market and generating revenue for VIVUS. For more information about the company, please visit www.vivus.com. ------------------------------------------------------------------------------------------------------------------------------------------------------------ (NASDAQ: GRMN - Garmin Ltd.) LATEST NEWS!! Garmin(R) Grows in Outdoor Recreation, Adding New Oregon(R) Handhelds, Garmin Connect(TM) Compatibility and Free Custom Maps Utility OLATHE, Kan., Dec 29, 2009 -- Garmin Ltd. (NASDAQ: GRMN), the global leader in satellite navigation, today announced the Oregon 450t and Oregon 450 touchscreen GPS devices, the newest of Garmin's next-generation outdoor handhelds now compatible with the online community at Garmin Connect as well as Garmin's free Custom Maps utility for transferring paper or digital maps onto your compatible handheld. "More than ever, Garmin offers intuitive touchscreen options for anyone exploring and enjoying the world around them," said Dan Bartel, Garmin's vice president of worldwide sales. "Oregon 450t and Oregon 450 provide a bridge between the slimmed-down Dakota(TM) family and the top-of-line Oregon 550t, all of which work seamlessly with Garmin Custom Maps in planning your adventure and Garmin Connect for reliving the experience and sharing the memories." Responsive to the touch of a finger, yet resistant to the rigors of nature, Oregon 450t and Oregon 450 simplify navigation through a glove-friendly touchscreen interface. This bright 3" color display is easier than ever to read and use in all conditions. Other key upgrades include user-selectable dashboards, enhanced track navigation, high-speed USB for faster map transfers with your computer, photo navigation and the 3-axis tilt-compensated electronic compass, which shows your heading even when you're standing still, without the need to hold it level. The new dashboards give users the ability to customize the appearance of various pages on your Oregon, including the geocaching, compass, stopwatch and elevation functions. For hikers, cyclists and trail runners, the enhanced track navigation will prove especially useful. When navigating to a destination on an active track, users will see the changes in elevation ahead of them as well as where they've been. Also, waypoints and other key locations along the active route -- such as start, end and high and low elevation points -- now appear on the map and active route pages. The new Oregon units also include a barometric altimeter, paperless geocaching and wireless exchange of tracks, waypoints, routes and geocaches with compatible Oregon, Dakota, Colorado(R) and Foretrex(R) devices. Both units boast a worldwide shaded relief basemap, and Oregon 450t adds preloaded 100K topographic maps for the entire United States and state-of-the-art 3D elevation perspective. Coverage on the 450t includes major trails, urban and rural roads, interstates, highways, coastlines, rivers and lakes as well as national, state and local parks, forests and wilderness areas. In addition, you can search for points of interest by name or proximity to your location and view descriptive details for terrain contours, topo elevations, summits and geographical points. Customizing maps for your Garmin outdoor handheld -- and downloading your activity afterward - were never easier. Through a few simple steps, Garmin's Custom Maps can bring the details, labels and landmarks of your existing paper or electronic map to a compatible Garmin Oregon, Dakota or Colorado. Compatible with both PC and Mac, this free utility complements the myriad of mapping products already offered for Garmin devices, including City Navigator(R), NT for turn-by-turn directions on city streets, Blue Chart(R) g2, for marine charting, and TOPO U.S. 24K and 100K map software for incredible terrain detail (each sold separately). The power of Custom Maps is exemplified through paper and digital maps labeled for specific events and purposes, such as a college graduation invitation that lists campus buildings; a roadmap of a parade, marathon, 5K or bike race; a park pamphlet showing trailheads; land-management maps of wildlife and game areas; or a historic illustration of an area as it once stood. To walk through the steps, to find and share maps and to join discussions about Garmin Custom Maps, visit www.garmin.com/CustomMaps. Experiences will live on long after the activity has ended, thanks to Garmin Connect's newly announced compatibility with Garmin outdoor handhelds, adding an expansive new product line to the free-to-join online community of more than 17 million activities -- with more than 38,000 new activities per day -- for sharing, storing, analyzing and enjoying. Outdoor and fitness enthusiasts alike can share activities on Facebook and Twitter, export to Google Earth or relive the activity in table view, calendar view or on a variety of maps including our new embedded Google Earth view. This December 2009 update also allows you to: easily upload to and from next-generation Garmin devices; manually upload .gpx files; send any track found at Garmin Connect in Explore to your Garmin Outdoor device for navigation; and export activity files in .gpx and .tcx format to use on third-party applications. Learn more and join Garmin Connect at http://connect.garmin.com. Weighing only 6.8 ounces, the Oregon 450t and Oregon 450 last up to 16 hours on two AA batteries. Each device has a high-sensitivity GPS receiver with HotFix(TM), which automatically calculates and stores critical satellite information and can use that information to quickly calculate a position. The new Oregon models have 850 MB of internal memory and a microSD(TM) card slot for photos and optional map data, and you can store up to 2,000 waypoints, 200 routes, 5,000 caches and a tracklog of up to 10,000 points and 200 saved tracks. Geocachers can help the environment and be more efficient by going paperless with Oregon by quickly downloading cache information directly to the device. Oregon stores and displays key information such as location, terrain, difficulty, hints and description, so that you don't have to tote printouts with you. Learn more about geocaching, getting started and going paperless at www.garmin.com/geocaching. Oregon 450t and Oregon 450 are the latest breakthroughs from Garmin, which has spent 20 years developing technologies and innovations to enhance users' lives, making Garmin a household name in the automotive, aviation, marine, wireless, outdoor and fitness industries. For more about features, pricing and availability, as well as information about Garmin's other products and services, go to www.garmin.com, www.garmin.blogs.com and http://twitter.com/jakesjournal. To watch step-by-step, feature-specific tutorial videos for Oregon, Dakota and other Garmin products, visit the online learning center at www.garmin.com/learningcenter. About Garmin International Inc. Garmin International Inc. is a subsidiary of Garmin Ltd. (Nasdaq: GRMN), the global leader in satellite navigation. Since 1989, this group of companies has designed, manufactured, marketed and sold navigation, communication and information devices and applications -- most of which are enabled by GPS technology. Garmin's products serve automotive, mobile, wireless, outdoor recreation, marine, aviation, and OEM applications. Garmin Ltd. is incorporated in the Cayman Islands, and its principal subsidiaries are located in the United States, Taiwan and the United Kingdom. For more information, visit Garmin's virtual pressroom at www.garmin.com ------------------------------------------------------------------------------------------------------------------------------------------------------------ (NASDAQ: TKTM - Ticketmaster Entertainment, Inc.) LATEST NEWS!! Ticketmaster Surpasses Sales of One Million Paperless Tickets in 2009 Paperless Initiative Enhances Fans' Access to Tickets, Helps Prevent Resellers from Boosting Prices for High-Demand Events; Named by Billboard Magazine as One of 2009's "Top 10 Stories of the Year" WEST HOLLYWOOD, Calif., Dec 29, 2009 -- Ticketmaster's Paperless Ticket(TM) (NASDAQ:TKTM) announced more than one million fans purchased tickets and attend live events. Since launching the paperless ticketing option, Ticketmaster has worked with many of the biggest names in sports and music including Bruce Springsteen, Metallica, AC/DC, University of Florida, John Mayer, Nine Inch Nails, Pennsylvania State University, Tom Waits, the Phoenix Suns, and San Antonio Spurs to help ensure their fans had access to tickets at the original listed price. 2009 also marked the first 100% paperless arena tour, the North American leg of Miley Cyrus's sell-out Wonder World tour. PAPERLESS BY THE NUMBERS: Top 5 Paperless Tickets Sold - All Events Top 5 Paperless Tickets Sold - Sports 1. University of Florida 1. NHL Phoenix Coyotes 2. Miley Cyrus North American Wonder World Tour 2. WNBA Connecticut Suns 3. University of South Alabama 3. NBA Phoenix Suns 4. Western Kentucky University 4. MLB Houston Astros 5. Pennsylvania State University 5. NBA San Antonio Spurs Top 5 Paperless Tickets Sold - Music Top 5 Paperless Tickets Sold - Universities 1. Miley Cyrus North American Wonder World Tour 1. University of Florida 2. AC/DC Black Ice World Tour 2. University of South Alabama 3. Bruce Springsteen and the E Street Working on a Dream 3. Western Kentucky University Tour 4. Tom Waits Glitter and Doom Tour 4. Pennsylvania State University 5. NIN Nine Inch Nails Wave Goodbye Tour 5. Louisiana Tech University Largest Single Paperless Event: Metallica (18,000) at 02 Arena in London, September 15, 2008 Top Venues With Permanent Paperless Integration: United States: Verizon Arena, North Little Rock, Ark. Canada: MTS Centre, Winnipeg, Manitoba Ticketmaster's Paperless Ticket(TM) has proven an effective method to limit ticket resale and better provide fans with access to tickets at the original face price set by the artist, team and/or promoter. For example, while the Miley Cyrus/Hannah Montana Best of Both Worlds tour was the top resold ticket of 2007, garnering an average ticket price of more than $250 on many of the top resale sites, the 2009 North American leg of Ms. Cyrus's sell-out Wonder World tour was 100% paperless, with an average ticket price of $68. "The success of our paperless technology establishes another viable ticket delivery option for our clients and fans," said Dave Butler, president, Ticketmaster North America. "We feel that paperless ticketing will become far more commonplace in the near future, and now our promoter, team and artist clients know without any doubt that paperless is a great, fan-friendly option for them should they choose to embrace this technology." The Verizon Arena in Little Rock, Ark., was the first venue to permanently install Ticketmaster's paperless ticketing technology. Michael Marion, general manager of Verizon Arena and a 25-year veteran of the live entertainment industry, states that paperless ticketing was "the next step of being able to help out our patrons to make sure that they pay the price that the artist wants them to pay. We've gotten nothing but positive feedback." The MTS Centre in Winnipeg, Manitoba, soon followed suit to become the first Canadian venue fully equipped to embrace paperless technology. Buying a paperless ticket is as simple as any regular ticket purchase, while helping guarantee that there's no waiting in line at will call and no tickets changing hands. When utilizing paperless tickets, fans do not receive a physical concert ticket for their entry into the event. On the day of the event, fans just need to bring the credit card they used for the ticket purchase and their government-issued photo ID to the concert. All members of the ticket purchaser's party must be present at the same time to enter the venue. The venue's ticket usher will swipe their credit card upon entry and present each person in their party with seat locator slips for quick access into the show. For more information on paperless ticketing visit http://www.ticketmaster.com/paperless. About Ticketmaster Entertainment, Inc. Ticketmaster Entertainment consists of Ticketmaster and Front Line Management Group. As the world's leading live entertainment ticketing and marketing company based on the number of tickets sold, Ticketmaster connects the world to live entertainment. Ticketmaster operates in 20 global markets, providing ticket sales, ticket resale services, marketing and distribution through www.ticketmaster.com, one of the largest e-commerce sites on the Internet; approximately 7,100 retail outlets; and 17 worldwide call centers. Established in 1976, Ticketmaster serves more than 10,000 clients worldwide across multiple event categories, providing exclusive ticketing services for leading arenas, stadiums, professional sports franchises and leagues, college sports teams, performing arts venues, museums, and theaters. In 2008, the Company sold more than 141 million tickets valued at over $8.9 billion on behalf of its clients. Ticketmaster Entertainment acquired a controlling interest in Front Line Management Group in October 2008. Founded by Irving Azoff and Howard Kaufman in 2004, Front Line Management Group is the world's leading artist management company. Ticketmaster Entertainment, Inc. is headquartered in West Hollywood, California (NASDAQ:TKTM). ------------------------------------------------------------------------------------------------------------------------------------------------------------ (NASDAQ: APPY - AspenBio Pharma, Inc.) LATEST NEWS!! AspenBio Pharma Reports Progress on the Supplemental Clinical Trial, Work to Improve the Clinical Utility of AppyScore(TM) and Scheduled Meeting With FDA Company Initiates Interim Trial Data Analysis; January Meeting With FDA CASTLE ROCK, CO, Dec 29, 2009 -- AspenBio Pharma, Inc. (NASDAQ: APPY), an emerging bio-science company dedicated to the development of novel diagnostics and drugs for humans and animals, reported on its progress and plans for the Premarket Notification 510(k) submission of its ELISA format AppyScore(TM) test. AppyScore is the first blood-based test designed to aid in the evaluation of patients suspected of having acute appendicitis. The previously announced AppyScore supplemental clinical trial continues to advance, with over 400 patients enrolled to-date from the emergency departments of more than a dozen well-known hospitals across the United States. Based upon additional analysis of prior trial data, as well as input from a panel of clinical experts assembled by AspenBio's regulatory consultants, the Statistical Analysis Plan ("SAP") for this supplemental trial has now been finalized. This SAP defines a study end point for the AppyScore test alone, and additionally, adds two alternative end points which evaluate the AppyScore result in combination with either white blood cell count ("WBC") or neutrophil count. Applying the parameters of this SAP in a retrospective analysis of the previous pivotal clinical trial data improved the negative predictive value ("NPV") of AppyScore to more than 95% in the subset of patients who have negative results for either the combination of AppyScore/WBC or AppyScore/neutrophil count. While there can be no absolute assurance that these results will be repeated in the current supplemental clinical trial, the company believes such results, if repeated would substantially enhance the clinical utility and value of AppyScore in the emergency department setting. The SAP provides for, and AspenBio has scheduled, an interim analysis of the clinical trial data to validate the required supplemental trial sample size necessary to achieve statistical significance for all study endpoints. Achieving statistical significance is essential for the inclusion of these important study end points in the submission of the Premarket Notification 510(k) information to the FDA, as well as describing clinical utility to physicians. This interim analysis was initially planned to be conducted with data from 250 patients; however, with the addition of the two new alternative study end points, a 400 patient interim data analysis will provide better predictive results of the final sample size needed. While patient recruitment continues uninterrupted, the interim analysis will be conducted in the upcoming weeks and is expected to be completed by late January or early February 2010. This analysis may demonstrate that the previously planned trial size is sufficient, or it may indicate a need to expand the size in order to achieve statistical significance of all end points. If an expansion of the trial is determined to be necessary, the timing for advancing the Premarket Notification 510(k) through the FDA will be evaluated and adjusted to ensure that the quality of the trial is not compromised and the clinical and statistical results are sound and compelling. In recent weeks a panel of clinical experts was convened to evaluate AppyScore's clinical utility and offer an independent opinion about its usefulness. Considering the currently available diagnostic modalities for appendicitis, the panel identified a strong need for better diagnostic tools to help identify a group of patients that is at low risk of having acute appendicitis. For this low-risk group, the panel indicated that a test with NPVs as high as those seen in the previous trial data when analyzed using the combination AppyScore/WBC or AppyScore/neutrophil count would provide compelling clinical evidence for the test to be widely used in evaluating patients suspected of having acute appendicitis. This panel also prepared a consensus paper expressing their opinion about the expected use of AppyScore in clinical practice. The clinical and regulatory direction the company is currently pursuing is in line with the opinions expressed in this paper. AppyScore is anticipated to be used as a diagnostic tool to aid emergency department physicians in identifying a subset of patients for whom the risk of acute appendicitis is sufficiently low to support consideration for delaying or eliminating the need for computed tomography (commonly known as a CAT scan) and/or immediate surgical consultation. To address the 510(k) and related matters, the company has scheduled a meeting with the FDA in January 2010. One of the objectives of the meeting is to ensure alignment with the FDA with respect to the data requirements necessary to support the proposed intended use and clinical utility of the AppyScore test. Following the meeting with the FDA and the completion of the interim data analysis, the company expects to be in a position to provide a further update to shareholders regarding the supplemental clinical trial patient size and plans for advancing 510(k) clearance. Dr. Robert Caspari, COO and CMO of AspenBio, commented: "We have received a clear message from our outside clinical experts, which is supported by our Medical Advisory Board, that the clinical value of AppyScore will be significantly enhanced by data that demonstrate that AppyScore achieves a negative predictive value substantially higher than current diagnostic modalities when used in conjunction with other commonly ordered diagnostic tests. We believe that taking the steps necessary to accomplish this objective will be well worth the time and costs and will result in added value." While the ELISA-based supplemental AppyScore trial has been preceding, AspenBio has also been advancing the development of its new stand alone, state-of-the-art cassette and reader instrument platform that provides AppyScore results more rapidly and efficiently than the ELISA format. This platform offers many benefits over an ELISA-based test. It can produce results in approximately 15 minutes, which in turn can be rapidly and accurately uploaded to a hospital's Laboratory Information System ("LIS") via a built-in electronic interface. More importantly, as a fully integrated, stand alone assay system, it can significantly reduce an operator's processing steps and the corresponding potential for errors. Clinical trials of the rapid assay are planned for 2010 and will be designed to support a 510(k) submission for this rapid assay platform using the ELISA test as a predicate, assuming the ELISA test is cleared by the FDA. In addition, these trials will provide AspenBio and physicians with additional information on the product's potential utility. The company expects to announce the execution of supply agreements with internationally recognized manufacturers for the rapid assay device and reader instrument as they are finalized. About AspenBio Pharma, Inc. AspenBio Pharma is an emerging bio-science company dedicated to the discovery, development and commercialization of novel products that address unmet diagnostic and therapeutic needs in both human and animal health. The company's AppyScore blood-based test addresses the difficult challenge of diagnosing human appendicitis in the hospital emergency department. The company is also advancing unique therapeutic proteins designed to improve reproduction in non-companion animals of economic importance. For more information, go to www.aspenbiopharma.com. ------------------------------------------------------------------------------------------------------------------------------------------------------------ (PINKSHEETS: ZVTK - Zevotek, Inc.) LATEST NEWS!! Zevotek Announces "Smooth Launch" for Ionic Bulb Sales NEW YORK, Dec 28, 2009 -- Zevotek, Inc., (Pink Sheets:ZVTK) (Frankfurt:T5V1), a worldwide direct marketer and distributor of innovative personal and home care items, today announced that customers who ordered Ionic Bulbs on Zevotek's www.newionicbulb.com website last week have already begun receiving their Ionic Bulbs. Commenting on the announcement, Zevotek's CEO, Adam Engel, said, "We are pleased to announce a smooth launch. It was important to get off to a quick clean start and have operations running smoothly in anticipation of ramped up sales volumes I expect from airing the Ionic Bulb infomercial nationwide. Our customers so far are often choosing to buy three or four Ionic Bulbs, which is a bigger sale than our two-bulb basic offer. I see that as an early positive sign." The Ionic Bulb is designed for consumer use by combining the performance features of ionic air cleaning technology with those of a 10,000 hour reduced energy use compact fluorescent light bulb (CFL). The Company previously announced that starting December 28, it will air its new 2-minute Ionic Bulb TV infomercial on U.S. cable channels. The Company announced that it is buying TV airtime to run the Ionic Bulb ad about 50 times between December 28, 2009 and January 3, 2010, with the ad expected to appear on FOXNews, Hallmark Movie Channel, History International, DIY Network, Planet Green, SOAPnet and New England Cable News Network. TV viewers of the Ionic Bulb infomercial can call a toll-free number to place orders for Ionic Bulbs. About the Company: Zevotek, Inc. plans to market and sell a range of innovative personal and home care items. Zevotek has a license to sell an energy saving compact fluorescent light bulb (CFL) named the Ionic Bulb. The Company sells the Ionic Bulb through TV infomercials and the Internet and plans to market Ionic Bulbs through catalogs, magazines and major U.S. retail and specialty stores. The Company's new 2 minute Ionic Bulb TV ad is designed to air on national cable channels, local broadcast channels and TV superstations. Zevotek's Ionic Bulb infomercial airs on the Company's www.newionicbulb.com website. ------------------------------------------------------------------------------------------------------------------------------------------------------------ About StockMarketingInc.com StockMarketingInc.com is a website that profiles stocks of interest. We are not licensed brokers or financial consultants. The information here is believed to be reliable, but not guaranteed to be accurate by StockMarketingInc.com. Please be advised that the information contained may or may not be complete and is solely for informational purposes only. This is not to be construed as an offer to sell, hold or the solicitation of an offer to buy. Investors are encouraged to seek opinions by their registered brokers or financial advisors after extensive due diligence is performed.
((Comments on this story may be sent to info@m2.com))
(c) 2009 M2 COMMUNICATIONS
Five Filters featured article: Chilcot Inquiry. Available tools: PDF Newspaper, Full Text RSS, Term Extraction. |
Auto Expo reflects India's growing global might - Hindu Business Line Posted: 29 Dec 2009 08:21 AM PST
Industry & Economy
-
Automobiles Auto Expo reflects India's growing global might A file photo of the 2008 Auto Expo in New Delhi. More visiors are expected this year. - Murali Gopalan Auto Expo 2010 may not have a showstopper like the Tata Nano that caught the fancy of the world during the 2008 event or the Tata Indica even further back in 1998. What is significant about the present Expo is that it well and truly showcases India's coming of age in the global auto arena when most other countries, barring China, just fell apart. Nobody in India Inc could have been as optimistic in the latter half of 2008 when the Lehman crisis shook the world. India felt the tremors too when the Sensex tanked and investors just went broke overnight. It was at this juncture that the Government stepped in and announced a series of fiscal incentives to ensure that industry could hold its own against the crisis. Rural Drive It was this intervention that prevented the auto industry from sinking into an abyss. "Things could have been terrible otherwise and the excise duty cuts on cars went a long way in stimulating demand," industry sources recall. Manufacturers also realised the potential of Rural India during these trying times and Maruti, Hyundai, Mahindra & Mahindra and many others cashed in on this opportunity in a big way. As a result, 2009 turned out to be one of the best years for the country's auto industry. It almost became routine for Maruti to churn out 75,000 cars on an average each month with rival Hyundai not doing too badly with over 40,000 units. Tata Motors' commercial vehicle business began slipping back to a degree of normalcy only during the last six months but its passenger car business did reasonable numbers. Pragati Maidan full up It is, therefore, in this context that the 2010 Expo in New Delhi is significant. The venue, Pragati Maidan, is already bursting at its seams with halls booked months in advance. As always, Tata Motors leads the pack, in terms of space booked, with nearly 5,500 square metres. Maruti is not too far behind with around 4,700 sq m with almost every big name in the global auto business part of this parade. Today, there are no two ways about the fact that the Delhi Auto Expo has well and truly arrived. The Tokyo Motor Show, held three months earlier, had little to offer and was largely seen as one showcasing the Japanese car industry. Today, only the Shanghai Auto Show can be termed bigger than the event in India though it would only be a matter of time before the gap is bridged even further. Little wonder, therefore, that some of the top brass of different companies will be present in New Delhi from January 5 when Pragati Maidan throws open its gates. Be it Toyota, Honda, Volkswagen or Renault, their management hotshots will be around to size up this exciting market. In their eyes, India represents a miracle when their countries just did not have a clue to handling the slowdown. Govt largesse This would not have happened had it not been for the reduction in excise duty on small cars to eight per cent (from 12 per cent) and others to 20 per cent (24 per cent). In addition, the Jawaharlal Nehru National Urban Renewal Mission (where cities got funds from the Centre for infrastructure) was the best piece of news for commercial vehicle manufacturers that saw new orders coming for their buses. Europe's scrappage scheme also helped with fuel-efficient cars from Maruti and Hyundai being picked up by customers in these markets. Halfway into 2009, carmakers' cheer seemed to be giving way to worry as a drought gripped parts of northern India. But they need not have worried as the drought did not deter customers one bit. Buying cars and two-wheelers continued at their frenzied pace though it was also clear that only new products did the trick. "Companies like Maruti, Hyundai, Mahindra & Mahindra and Bajaj Auto saw sales soar because they had something fresh to offer from time to time," sources said. Volkswagen's India Move The Expo is also important to some companies keen on sending out the right message of their intentions to the Indian market. Volkswagen, for instance, will showcase the Polo that will be launched in the coming months. The German carmaker, one of the most powerful players in the world market, has taken its time about entering India possibly because it had had a good run in China. VW's subsidiary, Skoda, has been around longer (since 2001) and has established itself as a premium player. It is now up to the parent to carve its own niche here. Clearly, VW's intent is quite aggressive going by the advertising blitzkrieg both on television and in print. "VW means business and its recent stake buyout in Suzuki reflects this intent," sources say. Similarly, Renault's stint in India with the Logan has been little to write home about and the French carmaker would be anxious to send the right message home at the Expo. Its Chairman, Mr Carlos Ghosn, said during a recent India visit that some important announcements were likely to be made around this time which would reiterate the company's long-term commitment to the market here. From the Japanese side, Honda and Toyota will showcase their small-car concepts at Pragati Maidan. Codenamed 800 L, the Toyota product is scheduled to debut during end-2010 while Honda's will follow a year later. Pricing will, of course, be the key in creating a presence in a segment where Maruti is well parked and is in no hurry to vacate the lot. Japanese concepts Both Honda are Toyota are expected to target their small cars for markets such as Brazil and Russia too though India will be the launch pad and possibly the most important hub for export of components to other countries. Likewise, Ford will have on display its Figo small car that was unveiled by its President, Mr Alan Mulally, in New Delhi some months ago. The American carmaker will be banking on this car to boost its India presence. Ford has often been criticised for being too slow on launching new products and the Figo could be a beginning to set right this perception. General Motors' Indian operations will now be part of a new 50:50 joint venture with Shanghai Automotive Industry Corporation. This will see the launch of Chinese-made light trucks and passenger cars in the near future which are intended to increase GM's market share in India. The company will be launching its Beat mini-car on January 4, a day ahead of the official opening of the Expo. Tata Motors and Mahindra & Mahindra will also showcase their commercial vehicles during the week-long event. Indications are that these could include the World Truck range from the former and latter's trucks being planned with ITEC of the US. Two-wheel rev up India's two-wheeler industry has also been doing brisk business of nearly 700,000 units each month and its Big Three — Hero Honda, Bajaj Auto and TVS Motor — will be present at the Expo. Yamaha and Suzuki, which are keen to increase their market share, will also be displaying their products. Special mention must be made of Honda Motorcycle & Scooter India, which within a decade, has emerged the clear market leader in gearless scooters and could end up being a force to reckon with in motorcycles. HMSI recently launched the 110cc Twister which will be on display at Pragati Maidan. More Stories on : Automobiles | Events
Article E-Mail :: Comment :: Syndication :: Printer Friendly Page
Five Filters featured article: Chilcot Inquiry. Available tools: PDF Newspaper, Full Text RSS, Term Extraction. |
Car dealers hope federal tax break deadline boost sales this week - San Jose Mercury News Posted: 29 Dec 2009 06:55 AM PST It's the most wonderful time of the year — for buying a new car. Savvy shoppers, desperate dealers and automotive analysts alike are singing that tune, thanks to fat rebates, cheap financing and an enticing federal tax break for buyers set to expire Friday. "I know we dealers always seem to say it, but with the tax benefits you'll get and the strong used-car values for trade-ins, this really is a great time to buy," said Mark Normandin, owner and president of Chrysler Jeep on Capitol Expressway Auto Mall in San Jose. "Normally at this time, we're all looking to close out the year as strong as we can. But it's been an especially difficult year and dealers are willing to take some pretty thin deals to move inventory."Experts say the car-lot deals are even better than last year, thanks largely to the tax break in the stimulus package approved by Congress in January. State and local sales and excise taxes on new vehicle purchases from Feb. 16 to New Year's Day are deductible on 2009 federal income taxes. Buyers can write off the taxes paid on the first $49,500 spent for a new car, light truck, motorcycle or motor home, potentially saving themselves thousands of dollars, depending on their tax bracket. With visions of tax relief dancing in his head, Victor Tabunshchik grabbed his 13-month-old son Maximilian and headed for Capitol Volkswagen Monday afternoon to engage in that time-honored tradition of price-wrangling for a new car. The 27-year-old clean-tech consultant from San Jose was hoping to trade in his 2004 Touareg for a 2010 diesel Jetta, taking advantage of the soon-to-expire tax break as well as a $1,300 tax credit the government is offering on a handful of diesel-powered vehicles.His decision, he said, was a no-brainer. "If you're looking for a new car, this is the time," Tabunshchik said. "With dealers desperate to move cars and the government offering you tax relief, you'd be dumb not to do it." Still, most of the car lots lining Capitol Expressway on Monday looked deserted, partly because of the rain but also because word of the tax break may not have gotten out to everyone. "I don't think consumers are aware of this" Normandin said. "We're trying to inform them in our ads that they only have a few more days to act and then it goes away." John Moore, who owns Moore Buick-Pontiac-GMC Truck in Los Gatos, said he was hopeful foot traffic would pick up once word spread. He called the current confluence of deals and tax breaks "a unique time." Before the federal government ended a sales tax deduction on new cars about 15 years ago, dealer showrooms were buzzing with buyers the last week of the year, Moore recalled. "We had phenomenal sales, and I'm assuming the same thing will happen this week," he said. Even if the last-minute buyers show up for the tax advantages and the zero-percent financing now available from many dealers, 2009 will remain a dreadful chapter in automotive history. Jessica Caldwell, a senior analyst with Edmunds, the Santa Monica-based clearinghouse for automotive information, said December sales should be healthier than December 2008, thanks to "manufacturers desperate to move metal and dealers desperate to meet sales objectives. But for the year, we'll still be down compared to last year's 13.2 million total units sold." Caldwell said sales "tanked in the last quarter of last year. And except for the Cash for Clunkers program, which made August a strong month, this year has been pretty low." Edmunds is predicting 10.4 million sales this year, a long way downhill from the 16.5 million new vehicles sold in 2006. Despite fewer sales, spokesman Chintan Talati says 2009 has provided better deals than 2008, pointing out that manufacturer incentives last spring were the highest they'd seen since Edmunds started tracking the figures in 2002. Those dangling lures helped bring Dhiru Desai, 68, down to the Auto Mall on Monday afternoon. The retired engineer knew it was time to replace his 1992 Lexus after it died on him at midnight in Danville as he and his wife were racing to Walnut Creek for the birth of their grandchild. "Because my income isn't that high, the tax break was not my primary motivation to buy a new car this week," he said, admiring a 2010 VW Tiguan, with a sticker price of $26,600. He was planning on coming back today for a test drive. "Even without the break, it's still a good time to buy," Desai said. "But my main reason to get a new car is that after my Lexus broke down, my wife said 'That does it — we cannot drive this thing anymore.' " Contact Patrick May at 408-920-5689. Five Filters featured article: Chilcot Inquiry. Available tools: PDF Newspaper, Full Text RSS, Term Extraction. |
Tax break nearly over for new-car buyers - Toledo Blade Posted: 29 Dec 2009 03:35 AM PST It was the older, less successful brother of "cash for clunkers" - a half-hearted effort to rekindle sagging auto sales included in the $787 billion federal stimulus package passed in February - and it is due to expire Thursday night. Chrysler LLC and General Motors Corp. filed for Chapter 11 bankruptcy in the spring and emerged in June and July, respectively, with additional financial help from the federal government. lvellequette@theblade.com or 419-724-6091. Five Filters featured article: Chilcot Inquiry. Available tools: PDF Newspaper, Full Text RSS, Term Extraction. |
Former NFL player, Reno car salesman Rick Kane dies at 55 - Reno Gazette Posted: 29 Dec 2009 01:12 AM PST Richard James Kane, a former professional football player who made his home in Reno, is being remembered as a great friend and inspiration. Kane, 55, known as "Rick," died Christmas morning at his home from complications from pneumonia, his family said. In April 2005, Kane lost his leg after a 17-year-old girl, distracted by her cell phone, crashed into his motorcycle near McCarran Boulevard and Manzanita Lane, police said. Kane would later help start a local amputee support group, said Rick Riley, of Prosthetic Consulting Tech. "I have been an amputee for 35 years and have been on the disabled ski team and climbed mountains," Riley said. "I get to inspire thousands of people. But from time to time, people come along who inspire me. That describes Rick Kane. He was an inspiration." Born in Lincoln, Neb., Kane grew up loving baseball, football and basketball. He was a running back at Oregon and San Jose State before being drafted in the third round in 1977 by the Detroit Lions. He played for the Lions in 1977-83 and for the Washington Redskins in 1984-85. Kane spent 25 years in the automotive business in Reno. He was the sales manager for 16 years at Reno Jeep Chrysler and spent the past four years at Scott Motor Co. as the Internet and fleet sales manager. Dave Bellamy, sales manager at Scott Motors, said Kane's co-workers were in shock over his sudden death and miss him terribly. "He had so many friends," Bellamy said. "He was just a nice guy whose greatest legacy was that people loved him, and he allowed people to become his friend. Everyone loved him." After Kane's accident, Bellamy said his personality was not changed and that he did not complain and had a positive attitude. A prosthetic leg allowed him to live a normal life. Riley said what mattered most to Kane was being able to be "a dad" and do activities with his children. Kane loved riding his Harley Davidson motorcycle with his wife, the outdoors and going on cross country RV trips with his family. "Rick was a special person and was everybody's friend," said Nan Nesbitt, formerly of Reno. "If he was your friend, he was your friend for life." He is survived by his wife of 13 years, Dianne; sons Ryan, Sean and John; daughter, Kelly and his mother, Anne Kane. Services are 11 a.m. Wednesday at the Church of Jesus Christ of Latter-day Saints, Lakeside Ward, 1095 Golconda Drive. Burial will follow at Mountain View Cemetery. Five Filters featured article: Chilcot Inquiry. Available tools: PDF Newspaper, Full Text RSS, Term Extraction. This posting includes an audio/video/photo media file: Download Now |
You are subscribed to email updates from Add Images to any RSS Feed To stop receiving these emails, you may unsubscribe now. | Email delivery powered by Google |
Google Inc., 20 West Kinzie, Chicago IL USA 60610 |
Tidak ada komentar:
Posting Komentar